Screening for disease, including cancer, can cause harm —during screening, diagnosis and treatment. With lung cancer ...

The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

When non-small cell lung cancer (NSCLC) spreads beyond the lungs, it often metastasizes to the bones. Estimates suggest 20 to 30 percent of people with NSCLC have bone metastases at the time of ...

The NHS is investing billions in revolutionary AI tools for cancer diagnosis - and patients are seeing the benefits ...